Sep 24, 2026 04:30PM

Jun 25, 2026 04:31PM

Jun 25, 2026 04:30PM

Mar 9, 2026 07:00AM

Aug 4, 2025 04:05PM

Jun 16, 2025 04:31PM

Jun 16, 2025 04:30PM Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases

Apr 3, 2025 07:00AM

Dec 23, 2024 07:05AM

Dec 23, 2024 07:00AM

Nov 6, 2024 07:00AM

Sep 27, 2024 05:15PM

Sep 11, 2024 07:00AM

Oct 5, 2023 07:00AM DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma

Jun 22, 2020 04:34PM

Jun 22, 2020 04:33PM

Jun 22, 2020 04:22PM

Mar 10, 2020 04:05PM

Mar 5, 2020 07:00AM

Jan 20, 2020 07:00AM

Jan 9, 2020 05:00PM Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2019 Performance Results, Delivering 29% DecisionDx-Melanoma Test Report Volume Growth in 2019

Dec 30, 2019 07:01AM

Dec 30, 2019 07:00AM

Nov 25, 2019 07:00AM

Nov 11, 2019 04:05PM

Oct 31, 2019 07:00AM

Oct 29, 2019 07:00AM

Oct 28, 2019 07:00AM Castle Biosciences Presents Second Study Confirming Ability of DecisionDx-Melanoma to Inform Sentinel Lymph Node Biopsy Decisions at the 8th International Congress on Cancer Metastasis

Oct 18, 2019 07:00AM

Sep 19, 2019 07:00AM

Sep 3, 2019 04:05PM

Jul 19, 2019 05:09PM

Jul 15, 2019 06:18AM

68,863 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All